REVB - Revelation Biosciences Inc

https://www.revbiosciences.com

Momentum: Bearish

Recent News

Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket - Revelation Biosciences ( NASDAQ:REVB )

Benzinga • 10 months ago • score: 0.24

Shares of Revelation Biosciences, Inc. REVB rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS results. Revelation Biosciences a reported quarterly loss of 84 cents per share compared to market estimates of a loss of $2.84 per share.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York.

52W High

$50.40

52W Low

$2.11

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.04

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

0.00

Forward P/E (<15 better)

0.89

EV/EBITDA (<8 favorable)

-1.02

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

2.88

P/B (<3 favorable)

1.28

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

0.90%

Institutions (25–75% balanced)

1.67%

Shares Outstanding

1,699,600

Float

1,684,300

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

90,905,000

EPS (TTM)

866.22

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-3.41%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.1591

-0.1007

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025